Professor George Werther MD, MSc(Oxon), FRACP George Werther graduated from The University of Melbourne and undertook paediatric training at The Royal Children's Hospital before spending time in Oxford, Cincinnati and Stanford, where he undertook training and laboratory research in diabetes and growth disorders. He has been a senior clinician/resarcher at the RCH and Murdoch Childrens Research Institute (MCRI) since 1983, and became Director of the Department of Endocrinology in 1999. He established the Centre for Hormone Research in 1991, within MCRI. He has played a leading role in Australian growth programs and research activities, both in the clinic and in the laboratory. His NHMRC-funded laboratory research in the field of insulin-like growth factors also resulted in the commercial development of 'antisense' molecular inhibitors of growth, now being developed in the ASX-listed company Antisense Therapeutics, of which he is a Board Director. His current laboratory research focuses on the critical role of the IGF system in both cancer and metabolism in early life, with implications for adult disease. He has trained a number of leading Australian and international paediatric endocrinologists.
Fergus Cameron BMedSci, MBBS, DipRACOG, FRACP, MD Fergus Cameron is the Director Diabetes Services, Deputy Director of the Department of Endocrinology and Diabetes and Director Healthy Bones Unit at The Royal Children's Hospital Melbourne. He is widely published in medical and lay literature regarding endocrine and diabetes management. His particular interests are the impacts of type 1 diabetes upon central nervous system development and psychosocial aspects of care. He is a council member for the International Society for Paediatric and Adolescent Diabetes, has given many invited plenary lectures and is the only southern hemisphere participant in the Hvidoere Study Group on Childhood Diabetes.
A/Professor Margaret ZacharinAssociate Professor Margaret Zacharin is a paediatric and adult endocrinologist. She is a fellow of the Royal Australasian College of Physicians and an examiner for the College. She has appointments as a consultant endocrinologist at Peter MacCallum as well as The Royal Children's Hospital and is an adjunct Professor at the University of New England, Armidale.
Her research interests include disorders of growth and puberty, osteoporosis and related conditions in primary bone disorders, chronic disease, hypogonadism, hormone replacement treatment and long term effects of cancer treatment, as well as essential vitamin status in communities. Current projects, with research grants of over $2,000,000, include trials of bisphosphonate use in several primary and secondary bone disorders of children, studies of endocrine problems after head injury in children, establishment of hormonal reference ranges in preterm infants, various studies in Turner syndrome and studies of children with inflammatory bowel disease. She has over 100 publications in peer-reviewed journals and has written a number of parent information booklets on bone health and hormone replacement in children with disabilities and long term effects of paediatric cancer, as well as editing multiple booklets on endocrine disorders.
Dr Michele O'Connell
Dr Matthew Sabin MB BS(Hons) BSc(Hons) MRCPCH FRACP PhDDr Matt Sabin trained at Guy's and St Thomas' Hospitals in London, UK and undertook general paediatric training in England, before completing higher specialist training in paediatric endocrinology and diabetes in Melbourne, Australia. He is as a consultant in the Department of Endocrinology and Diabetes at The Royal Children's Hospital Melbourne, a senior research fellow at the Murdoch Childrens Research Institute, a lecturer at The University of Melbourne, and an adjunct senior lecturer in physiology at Monash University. His PhD investigated the links between childhood obesity and early type 2 diabetes, and he has built his current research program from this platform.
He is nationally and internationally recognised as an expert in the clinical management of overweight and obese children, and is a current recipient of an NHMRC Postdoctoral Training Fellowship for his work in this area. He is a member of the Royal College of Paediatrics and Child Health in the UK, and a fellow of the Royal Australasian College of Physicians.
Current clinical research endeavours involve the collection of comprehensive data from overweight and obese children allowing further investigation into the role of genetics vs environment in the development of obesity-related disease. Laboratory research focuses on investigations into the role that early nutrition plays in altering susceptibility to later obesity and diabetes, as well as probing ways in which processes underlying these relationships can be altered by growth factors and modulators of inflammation.
Dr Peter Simm MBBS (Hons) MD FRACP Peter trained in paediatric endocrinology at the RCH from 2005 until 2008. He completed his post fellowship training at Children's Hospital, Westmead, Sydney (2009-10), with a special interest in paediatric bone and mineral disorders. He has appointments at the RCH and Monash Children's, with clinical interests including paediatric bone and mineral disorders, growth and diabetes transition. He provides reports for the clinical densitometry service at the RCH. He is currently involved in a number of research projects exploring bone health issues in young people.
In This Section
Telephone +61 3 9345 5522
50 Flemington Road Parkville
Victoria 3052 Australia